Roger Cressey – Executive Director, Commercial & Operations – Gold Hydrogen (ASX:GHY) specialises in natural power from hydrogen, a sustainable form of natural gas harvested in Australia.
Copyright 2024 – Finance News Network
Source: Finance News Network
30 Sep 2019 - Symposium, Managing Director, Kerry Stevenson talks about the importance of gold in a diversified portfolio, its successful performance over the past 12 months and all that’s on offer at this year’s event, 24-26 October, Sydney Sofitel Wentworth.
Read More07 Apr 2025 - The Final Steps in Drug Development and Market Access
Read More30 Mar 2022 - BluGlass Limited (ASX:BLG) Executive Chair discusses the acquisition of a semiconductor manufacturing lab in Fremont in the Silicon Valley.
Read More22 Nov 2022 - Radiopharmaceutical Theranostics Limited (ASX:RAD) Managing Director and CEO Riccardo Canevari discusses the progress of the company's brain, lung and prostate cancer therapies.
Read More01 Oct 2024 - Hazer Group Limited (ASX:HZR) CEO Glenn Corrie provides an update on the company, discussing IP protection and moving into commercialisation.
Read More28 Aug 2024 - Focused on supplying high-purity manganese for electric vehicles, Euro Manganese Limited (ASX:EMN) is advancing a project in the Czech Republic that repurposes historical mine tailings. The company's recent offtake agreement with Wildcat Discovery Technologies is a significant milestone, with more agreements and funding efforts planned for the near future.
Read More03 Mar 2025 - Addressing Unmet Needs in Cancer Care
Read More25 Oct 2024 - In the keynote address for the inaugural Semiconductor Australia conference, Digital Playground Co-Founder and General Partner Peter Barrett discusses Australia's potential to lead in next-generation technology.
Read More03 Feb 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook provides an update on the company's record December quarter results, progress with strategic partners and overseas expansion plans.
Read More10 Jul 2023 - INOVIQ Limited (ASX:IIQ) CEO Dr Leearne Hinch discusses recent news, including excellent sensitivity and specificity results for the company's SubB2M breast cancer test.
Read More
